Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Neonc Technologies, Inc.
AstraZeneca
M.D. Anderson Cancer Center
AbbVie
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National University Hospital, Singapore
Merck Sharp & Dohme LLC
Thomas Jefferson University
National University Hospital, Singapore
Taiho Pharmaceutical Co., Ltd.
Zhejiang Cancer Hospital
The University of Texas Health Science Center at San Antonio
Centre Leon Berard
Second Affiliated Hospital of Guangzhou Medical University
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago
University of Pittsburgh
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
Duke University